Taken together, our data show that plasma fetuin-A levels correlated negatively with inflammatory cytokines/chemokines and various activation biomarkers in T2D patients, indicating that the circulatory fetuin-A may have predictive importance as a negative APP in metabolic disease. Here, AHSG is linked to type 2 diabetes mellitus.